<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Knechtle, Philipp</dc:creator>
  <dc:creator>Diefenbacher, Melanie</dc:creator>
  <dc:creator>Greve, Katrine B. V.</dc:creator>
  <dc:creator>Brianza, Federico</dc:creator>
  <dc:creator>Folly, Christophe</dc:creator>
  <dc:creator>Heider, Harald</dc:creator>
  <dc:creator>Lone, Museer A.</dc:creator>
  <dc:creator>Long, Lisa</dc:creator>
  <dc:creator>Meyer, Jean-Philippe</dc:creator>
  <dc:creator>Roussel, Patrick</dc:creator>
  <dc:creator>Ghannoum, Mahmoud A.</dc:creator>
  <dc:creator>Schneiter, Roger</dc:creator>
  <dc:creator>Sorensen, Alexandra S.</dc:creator>
  <dc:date>2014-01-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Human fungal infections represent a therapeutic challenge. Although effective strategies for treatment are available, resistance is spreading, and many therapies have unacceptable side effects. A clear need for novel antifungal targets and molecules is thus emerging. Here, we present the identification and characterization of the plant-derived diyne-furan fatty acid EV-086 as a novel antifungal compound. EV-086 has potent and broad-spectrum activity in vitro against Candida, Aspergillus, and Trichophyton spp., whereas activities against bacteria and human cell lines are very low. Chemical-genetic profiling of Saccharomyces cerevisiae deletion mutants identified lipid metabolic processes and organelle organization and biogenesis as targets of EV-086. Pathway modeling suggested that EV-086 inhibits delta-9 fatty acid desaturation, an essential process in S. cerevisiae, depending on the delta-9 fatty acid desaturase OLE1. Delta-9 unsaturated fatty acids—but not saturated fatty acids—antagonized the EV-086-mediated growth inhibition, and transcription of the OLE1 gene was strongly upregulated in the presence of EV-086. EV-086 increased the ratio of saturated to unsaturated free fatty acids and phosphatidylethanolamine fatty acyl chains, respectively. Furthermore, EV-086 was rapidly taken up into the lipid fraction of the cell and incorporated into phospholipids. Together, these findings demonstrate that EV-086 is an inhibitor of delta-9 fatty acid desaturation and that the mechanism of inhibition might involve an EV-086–phospholipid. Finally, EV-086 showed efficacy in a guinea pig skin dermatophytosis model of topical Trichophyton infection, which demonstrates that delta-9 fatty acid desaturation is a valid antifungal target, at least for dermatophytoses.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/303516</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/303516/files/sch_ndf.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1128/AAC.01443-13</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Antimicrobial Agents and Chemotherapy. - 2013, vol. 58, no. 1, p. 455–466</dc:source>
  <dc:subject>info:eu-repo/classification/udc/615</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">The natural diyne-furan fatty acid EV-086 is an inhibitor of fungal delta-9 fatty acid desaturation with efficacy in a model of skin dermatophytosis</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
